Spyra, the innovative Munich-based tech company renowned for its high-tech premium water blasters, is making waves in the toy industry with an exciting funding announcement. The company has successfully raised €5 million in its latest funding round, a significant investment that will fuel its ongoing mission to create exhilarating and immersive experiences that bring joy to people of all ages. With this new capital, Spyra plans to enhance its product development, focusing on further innovation within its flagship SpyraBlasters, which have already redefined the art of water battles and established themselves as the world's strongest water blasters. Underpinning their success is a dedicated team of 25 young engineers and enthusiasts, whose ingenuity and passion continue to drive the brand forward. This funding will enable Spyra to solidify its position as a global leader in the premium toy market, expanding its reach and influence while exploring new technologies that will elevate the water battle experience to uncharted heights. As they embark on this exciting new chapter, Spyra invites everyone to join in the adventure, promising even more thrilling water warfare and unforgettable moments with family and friends through their cutting-edge products. The future is bright for Spyra, and with this new financial backing, they are poised to make a splash in the world of high-tech play.
Spyra Makes a Splash with Game-Changing Funding Round!
Get the full Spyra company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
White Circle
White Circle is the control layer for AI in production. We help companies test, protect, observe, and improve every AI interaction — from blocking unsafe inputs and preventing jailbreaks to analyzing user behavior and optimizing model performance.
$11.0M Seed
today
Hoplon AI
Human Convesation, Super Human Protection - Always on
$1.0M Seed
today
Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
$2.1B Series b
today
Sensible Medical Innovations Ltd.
Sensible Medical has developed a non-invasive fluid status monitor (ReDS) for accurate measurement and monitoring of lung fluid for heart failure patients.
$20.0M Unknown
today
Replenish, Inc.
Replenish, Inc. developed the world's smallest implantable, refillable drug pump for the $7 billion retinal therapeutic market (pump currently in clinical investigation, not yet approved by FDA for sale). The MicroPump is implanted under the eye's skin for the purpose of periodically injecting sight-saving medication for patients with age related macular degeneration (AMD). After a 20 minute outpatient surgical procedure, the pump is programmed and recharged wirelessly by the physician and refilled ever 6 months to deliver biotech protein therapies that could only be otherwise administered by a physician's syringe every 4 weeks for life. See our website at www.replenishinc.com for more information.
$100.0K Unknown
today